PMID 10833429
Clearly the role of lipotoxicity between ethnic cohorts requires further investigation, as does determining the exact concentration of FFA that -cells are exposed to in vivo
A total of 200 mg/kg of GSH (available in Japan as Tathion, Yamanouchi Pharmaceutical, Tokyo, Japan) was administered intra-venously to 10 patients before cardiopulmonary bypass surgery, and the influence on postoperative renal dysfunction was compared with 9 other patients undergoing the same procedure without GSH administration
PLoS ONE 9 , e100286 (2014)
It binds to ghrelin receptors in the pituitary through a completely separate mechanism
But - clinical trials aren't substantial, it's still not approved for use (indicating more safety data is warranted), most work is pre-clinical and or done with rodents not humans and given its ability to upregulate human growth hormone and angiogenesis (create new blood vessels), someone with a history of cancer would be advised to take serious precautions